COPIED
3 mins

CLINICAL

RETHINKING THE RESEARCH

Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.

Critical appraisal is, in my opinion, one of the most undervalued skills in aesthetic medicine. We devote considerable attention to learning how to deliver treatments. We should be equally concerned with how we decide whether those treatments are worth delivering and whether the evidence supports what we tell our patients.

THE GAP IN OUR EDUCATION

For many of us, entering aesthetic medicine means becoming self-employed and taking responsibility for our own education. We choose our courses, conferences and mentors. That freedom is valuable, but it also means that the content and quality of our education depend on our own judgement.

Compare this with the route of a typical NHS surgical trainee. From medical school onwards, trainees encounter repeated competitive bottlenecks, particularly when applying for core surgical and higher specialty training, and later for consultant appointments. Academic achievements, including publications, presentations and higher research degrees, can strengthen an application.

Alongside journal clubs, supervision and academic discussion, they create opportunities to understand how studies are designed, where bias arises and why a conclusion may exceed the findings. A publication record does not guarantee sound critical judgement, but the training environment repeatedly encourages clinicians to engage with the literature.

A DIFFERENT EDUCATIONAL LANDSCAPE

Aesthetic medicine has no equivalent shared sequence of academic incentives. Clinicians enter from different professions and at different career stages.

Those moving into independent practice early may have had fewer opportunities to develop these skills.

This variation reflects different educational journeys, but it has consequences when we are all expected to assess increasingly sophisticated treatment claims.

Much of our continuing education is delivered or supported by manufacturers and distributors. However, its commercial interests influence which products are studied, which findings receive attention and how those findings are presented. A scientifically accurate slide can still convey a selective account of the evidence.

EVIDENCE AS A MARKETING CLAIM

The difficulty is often the distance between a finding and the claim built upon it. Increased collagen expression in a laboratory experiment may be presented as evidence of clinical rejuvenation. Improvement in an uncontrolled study may become a claim of superiority. A small study with short follow-up may be used to offer reassurance about safety that it was never designed to establish. Each step can sound plausible while extending beyond what has scientifically been demonstrated.

This is of utmost importance because treatment decisions carry clinical and financial consequences for patients. If we cannot interrogate the evidence ourselves, we risk adopting protocols because they are confidently taught, without understanding their limitations. Our own investment in a product, or our relationship with a company, can make that scrutiny more uncomfortable. It also makes it more necessary.

RESEARCH UNDER THE MICROSCOPE

From a practical perspective, critical appraisal becomes more manageable when approached systematically. The Critical Appraisal Skills Programme (CASP) provides checklists for different study designs, organised around validity, results and clinical relevance. The appropriate checklist should be used for the paper being read.

As a starting point, I would encourage clinicians to ask the following five questions, informed by those principles:

1. What question does this study answer? Identify the population, intervention, comparator and outcome.

2. Is the study design capable of supporting the conclusion? Consider the control group, randomisation, blinding, sample size and follow-up.

3. How large and credible is the benefit? Look beyond statistical significance. Examine effect sizes, confidence intervals and validated outcomes.

4. Where might bias have entered? Examine recruitment, missing data, selective reporting, funding and conflicts of interest.

5. Should these findings change my practice? Check whether the patients, product and protocol reflect your practice.

These questions are a starting point, and the skill develops through repeated use. We do not all need to become researchers. We do, however, need sufficient understanding to recognise the limits of the evidence on which we base our decisions. In a field where so much education arrives through commercial channels, independent appraisal should be a routine part of clinical practice. At the end of it all, patients are relying on our judgement when they agree to treatment.

Scan for references:

JORDAN FAULKNER

Dr Jordan Faulkner is a full-time cosmetic physician and founder of Allo Aesthetics. He is the founder and lead mentor of Unite Aesthetics Initiative and is a clinical educator at Interface Aesthetics. Dr Faulkner is a brand ambassador at Revanesse and faculty member at DermaFocus. He is the co-owner of Myokine Ltd. He won Rising Star of the Year at the Aesthetics Awards ‘25.

This article appears in Nov/dec 2026

Go to Page View
This article appears in...
Nov/dec 2026
Go to Page View
DEAR READERS
There’s always something new to talk about in
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
SKIN QUALITY REDEFINED
As skin quality becomes an increasingly prominent focus in aesthetic practice, Teoxane introduces babyGLOW™ and babyGLOW™ for HIM, two protocols designed to address skin revitalisation with a focus on precision and natural-looking results. 1
HOT OFF THE PRESS
UK government launches consultation on high-risk cosmetic procedures
OUT & ABOUT
REJURAN PRESS TRIP Seoul and Gangneung, South Korea
JEN VITTANUOVA IS… LEGALLY AESTHETIC
Funny, frank and fiercely attached to her patients, Jen Vittanuova is bringing her experience as an aesthetic nurse and expert witness into education. With Legally Blonde as her muse, she is making the case for better consent, sharper records and safer clinics, discovers Kezia Parkins .
CASE STUDY: CHRONIC ACNE AND SCARRING TRANSFORMATION
Treating chronic acne and post-acne concerns with a personalised combination approach
PDRN VS PN: WHAT AESTHETIC PRACTITIONERS NEED TO KNOW
As PDRN moves into topical skincare and injectable polynucleotides gain prominence in clinics, confusion surrounding the two categories is growing. Ellen Cummings examines their proposed mechanisms, evidence and implications for clinical practice.
BEYOND THE SURFACE
A multi-layer approach to skin rejuvenation with RF Microneedling
NEXT UP
Claudia McGloin asks: what should really define the next trend in regenerative injectables?
THE EVOLVING BOOB JOB
Consultant plastic surgeon Paul Banwell on awake surgery, tissue preservation, implant innovation and the future of the “boob job”.
BEYOND THE TEMPLATE
Dr Ahmed El Muntasar argues that safe, individualised aesthetic care requires practitioners to understand anatomical variation, assess skin characteristics and question whose beauty standards shape treatment.
CLINIC TO COSMETIC COUNTER
Dr Farah Latif and Prof Ali Al -Hussaini ask: are professional treatments becoming beauty products?
UNDERSTANDING ICHTHYOSIS VULGARIS
Dr Kemi Fabusiwa and Professor Edel O’Toole explain how to recognise, manage and treat ichthyosis vulgaris, from protecting the skin barrier to supporting patients with long-term care.
RETHINKING THE RESEARCH
Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.
PRACTICALLY PERFECT?
As Practical Magic 2 hits cinemas, 28 years after the original, its female stars have ignited a debate around ageing: don’t have too much work done, but don’t show any signs of ageing. Vicky Eldridge asks: how can women in aesthetic medicine help to change the narrative?
PRECISION FIRST
Emma Wedgwood looks into why the next big thing in 2027 will not be a treatment, but precision.
WHEN TRENDS TRAVEL FASTER than governance
From glass skin to treatment stacking, South Korea is shaping patient expectations. But does faster adoption mean better practice? Jen Vittanuova explores what UK aesthetics can learn, and why clinical judgement must keep pace with innovation.
THE UNSEEN WORK OF EXCELLENCE
Why clinical excellence depends on consistent standards, practical experience and knowing when to keep learning.
THE PURSUIT OF EXPERTISE OR THE PURSUIT OF RECOGNITION?
Amy Bird questions whether aesthetic medicine is prioritising visibility and recognition over clinical knowledge.
LEAD WITH THE CONDITION NOT THE CURE
Why condition-led websites win more consultations and keep you on the right side of the ASA.
ASK THE EXPERTS
Which health factors could influence treatment outcomes?
THE INTELLIGENT CLINIC
Dr Askari Townshend looks into why the future of aesthetics will be driven by data.
HOW AI SEARCH IS CHANGING WHERE PATIENTS FIND AESTHETIC CLINICS
AI is changing how patients discover aesthetic clinics. Panita Vig explains what AI search means for clinic visibility and the practical steps practitioners can take now to stay discoverable.
RETHINKING CLINICAL STYLE
Ditching the traditional clinical look, Emma Wedgwood shares how she transformed her treatment room into a space that reflects her style and personality.
PROTECT YOUR PRACTICE
Asking the right questions now can help protect your practice, reputation and clients later,
HYDRAFACIAL NANO-NEEDLING
Connie Cooper visited the Hydrafacial flagship to try their latest treatment: Hydrafacial Deluxe with SkinStylus Nano-Needling.
DOUBLE CHIN TIGHTENING WITH XERF
Contributing reporter Anna Dobbie visits the Seriderm Training Centre to experience XERF, a non-invasive radiofrequency treatment that tightens and firms the skin beneath her chin.
PRODUCT NEWS
AlumierMD AlumierMD has expanded its Biocellulose range with
5 MINUTES WITH ... IAIN DE HAVILLAND
Founder of NADclinic Group, Iain De Havilland discusses evolution of NAD+ therapy and the growing role of personalised longevity medicine in aesthetics.
5 ANATOMY EXPERTS TO FOLLOW
These five specialists are putting facial anatomy, clinical knowledge and education at the forefront of aesthetics.
Looking for back issues?
Browse the Archive >

Previous Article Next Article